Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

17 trials with published results (16%)

Research Maturity

57 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.7%

4 terminated out of 108 trials

Success Rate

93.4%

+6.9% vs benchmark

Late-Stage Pipeline

6%

6 trials in Phase 3/4

Results Transparency

30%

17 of 57 completed with results

Key Signals

17 with results93% success

Data Visualizations

Phase Distribution

91Total
Not Applicable (69)
P 1 (1)
P 2 (15)
P 3 (5)
P 4 (1)

Trial Status

Completed57
Recruiting19
Unknown13
Active Not Recruiting9
Terminated4
Withdrawn3

Trial Success Rate

93.4%

Benchmark: 86.6%

Based on 57 completed trials

Clinical Trials (108)

Showing 20 of 20 trials
NCT05473013Not ApplicableRecruiting

Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

NCT05304104Not ApplicableCompletedPrimary

Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans

NCT05540704Not ApplicableRecruiting

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

NCT06848244Not ApplicableActive Not Recruiting

Preventing Type 2 Diabetes in Black Emergent Adult

NCT04724668Not ApplicableCompletedPrimary

The Role of the Circadian System in Binge Eating Disorder

NCT05664516Phase 2RecruitingPrimary

A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

NCT06878976Phase 3Enrolling By InvitationPrimary

A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder

NCT05693896Not ApplicableNot Yet Recruiting

Treating Binge Eating and Obesity Digitally in Women

NCT03393039Not ApplicableActive Not Recruiting

Effects of Negative Affect in Individuals With Binge Eating Episodes

NCT06413433Phase 3RecruitingPrimary

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

NCT06819813Not ApplicableActive Not Recruiting

Project VIBE: Virtual Intervention for Binge Eating in Adolescents

NCT06594913Recruiting

Eating Disorders Genetics Initiative 2

NCT04125589Not ApplicableCompletedPrimary

Decision Making, Daily Experiences, and Brain Activity in Young Adult Women

NCT04701671Active Not Recruiting

Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids

NCT06602973Not ApplicableCompleted

Relationships Between Exercise and Appetite in Women With Loss of Control Eating

NCT06858774Not ApplicableRecruitingPrimary

Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder

NCT07237607Not ApplicableRecruiting

Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

NCT06325670Not ApplicableCompleted

Type 2 Diabetes and Binge Eating Disorder (BED)

NCT04174703Not ApplicableEnrolling By Invitation

Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing

NCT07060534Not ApplicableRecruiting

Building Healthy Eating and Self-Esteem Together for University Students

Scroll to load more

Research Network

Activity Timeline